| Patient-derived xenograft and organoid models for precision medicine targeting of the tumour microenvironment in head and neck cancer TW Lee, A Lai, JK Harms, DC Singleton, BD Dickson, AMJ Macann, ... Cancers 12 (12), 3743, 2020 | 26 | 2020 |
| Impact of tumour hypoxia on evofosfamide sensitivity in head and neck squamous cell carcinoma patient-derived xenograft models JK Harms, TW Lee, T Wang, A Lai, D Kee, JM Chaplin, NP McIvor, ... Cells 8 (7), 717, 2019 | 19 | 2019 |
| Enhanced bioactivity of a human GHR antagonist generated by solid-phase site-specific PEGylation Y Wang, RJ Langley, K Tamshen, J Harms, MJ Middleditch, HD Maynard, ... Biomacromolecules 22 (2), 299-308, 2020 | 8 | 2020 |
| Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models TW Lee, DC Singleton, JK Harms, M Lu, SP McManaway, A Lai, M Tercel, ... Molecular Oncology, 2024 | | 2024 |
| Therapeutic Targeting of Hypoxia in Xenograft Models of Head and Neck Cancer J Harms Masters Thesis-University of Auckland, 2019 | | 2019 |
